help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deckers, M. M. L.
Right arrow Articles by Löwik, C. W. G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deckers, M. M. L.
Right arrow Articles by Löwik, C. W. G. M.
Endocrinology Vol. 143, No. 4 1545-1553
Copyright © 2002 by The Endocrine Society


GROWTH FACTORS-CYTOKINES-ONCOGENES

Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A

Martine M. L. Deckers, Rutger L. van Bezooijen, Geertje van der Horst, Jakomijn Hoogendam, Chris van der Bent, Socrates E. Papapoulos and Clemens W. G. M. Löwik

Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands

Address all correspondence and requests for reprints to: Dr. C.W.G.M. Löwik, Department of Endocrinology, Leiden University Medical Center, Building 1, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. E-mail: . c.w.g.m.lowik{at}lumc.nl

During bone formation and fracture healing there is a cross-talk between endothelial cells and osteoblasts. We previously showed that vascular endothelial growth factor A (VEGF-A) might be an important factor in this cross-talk, as osteoblast-like cells produce this angiogenic factor in a differentiation-dependent manner. Moreover, exogenously added VEGF-A enhances osteoblast differentiation. In the present study we investigated, given the coupling between angiogenesis and bone formation, whether bone morphogenetic proteins (BMPs) stimulate osteoblastogenesis and angiogenesis through the production of VEGF-A. For this we used the murine preosteoblast-like cell line KS483, which forms mineralized nodules in vitro, and an angiogenesis assay comprising 17-d-old fetal mouse bone explants that have the ability to form tube-like structures in vitro.

Treatment of KS483 cells with BMP-2, -4, and -6 enhanced nodule formation, osteocalcin mRNA expression, and subsequent mineralization after 18 d of culture. This was accompanied by a dose-dependent increase in VEGF-A protein levels throughout the culture period. BMP-induced osteoblast differentiation, however, was independent of VEGF-A, as blocking VEGF-A activity by a VEGF-A antibody or a VEGF receptor 2 tyrosine kinase inhibitor did not affect BMP-induced mineralization.

To investigate whether BMPs stimulate angiogenesis through VEGF-A, BMPs were assayed for their angiogenic activity. Treatment of bone explants with BMPs enhanced angiogenesis. This was inhibited by soluble BMP receptor 1A or noggin. In the presence of a VEGF-A antibody, both unstimulated and BMP-stimulated angiogenesis were arrested. Conditioned media of KS483 cells treated with BMPs also induced a strong angiogenic response, which was blocked by antimouse VEGF-A but not by noggin. These effects were specific for BMPs, as TGFß inhibited osteoblast differentiation and angiogenesis while stimulating VEGF-A production.

These findings indicate that BMPs stimulate angiogenesis through the production of VEGF-A by osteoblasts. In conclusion, VEGF-A produced by osteoblasts in response to BMPs is not involved in osteoblast differentiation, but couples angiogenesis to bone formation.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. M. Smadja, I. Bieche, J.-S. Silvestre, S. Germain, A. Cornet, I. Laurendeau, J.-P. Duong-Van-Huyen, J. Emmerich, M. Vidaud, M. Aiach, et al.
Bone Morphogenetic Proteins 2 and 4 Are Selectively Expressed by Late Outgrowth Endothelial Progenitor Cells and Promote Neoangiogenesis
Arterioscler. Thromb. Vasc. Biol., December 1, 2008; 28(12): 2137 - 2143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Song, L. Coleman, J. Shi, H. Beppu, K. Sato, K. Walsh, J. Loscalzo, and Y.-Y. Zhang
Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H677 - H690.
[Abstract] [Full Text] [PDF]


Home page
Journal of Bioactive and Compatible PolymersHome page
S. Kokubo, K. Nozaki, S. Fukushima, K. Takahashi, K. Miyata, R. Fujimoto, and S. Yokota
Recombinant Human Bone Morphogenetic Protein-2 as an Osteoinductive Biomaterial and a Biodegradable Carrier in a Rabbit Ulnar Defect Model
Journal of Bioactive and Compatible Polymers, July 1, 2008; 23(4): 348 - 366.
[Abstract] [PDF]


Home page
Stem CellsHome page
Y. Mifune, T. Matsumoto, A. Kawamoto, R. Kuroda, T. Shoji, H. Iwasaki, S.-M. Kwon, M. Miwa, M. Kurosaka, and T. Asahara
Local Delivery of Granulocyte Colony Stimulating Factor-Mobilized CD34-Positive Progenitor Cells Using Bioscaffold for Modality of Unhealing Bone Fracture
Stem Cells, June 1, 2008; 26(6): 1395 - 1405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kotzsch, J. Nickel, A. Seher, K. Heinecke, L. van Geersdaele, T. Herrmann, W. Sebald, and T. D. Mueller
Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome
J. Biol. Chem., February 29, 2008; 283(9): 5876 - 5887.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
Z.S. AI-Aql, A.S. Alagl, D.T. Graves, L.C. Gerstenfeld, and T.A. Einhorn
Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis
J. Dent. Res., February 1, 2008; 87(2): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
FAKE JDRHome page
Z.S. AI-Aql, A.S. Alagl, D.T. Graves, L.C. Gerstenfeld, and T.A. Einhorn
Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis
Journal of Dental Research, February 1, 2008; 87(2): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
W. M. Novicoff, A. Manaswi, M. V. Hogan, S. M. Brubaker, W. M. Mihalko, and K. J. Saleh
Critical Analysis of the Evidence for Current Technologies in Bone-Healing and Repair
J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 85 - 91.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
X. Pi, R. Ren, R. Kelley, C. Zhang, M. Moser, A. B. Bohil, M. DiVito, R. E. Cheney, and C. Patterson
Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors
J. Cell Biol., December 31, 2007; 179(7): 1569 - 1582.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J. Astorga and P. Carlsson
Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4
Development, October 15, 2007; 134(20): 3753 - 3761.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
K. Watanabe, H. Tsuchiya, K. Sakurakichi, and K. Tomita
Bone transport using hydroxyapatite loaded with bone morphogenetic protein in rabbits
J Bone Joint Surg Br, August 1, 2007; 89-B(8): 1122 - 1129.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Scharpfenecker, M. van Dinther, Z. Liu, R.L. van Bezooijen, Q. Zhao, L. Pukac, C. W. G. M. Lowik, and P. ten Dijke
BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis
J. Cell Sci., March 15, 2007; 120(6): 964 - 972.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yao, A. F. Zebboudj, E. Shao, M. Perez, and K. Bostrom
Regulation of Bone Morphogenetic Protein-4 by Matrix GLA Protein in Vascular Endothelial Cells Involves Activin-like Kinase Receptor 1
J. Biol. Chem., November 10, 2006; 281(45): 33921 - 33930.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
H. J. Seeherman, K. Azari, S. Bidic, L. Rogers, X. J. Li, J. O. Hollinger, and J. M. Wozney
rhBMP-2 Delivered in a Calcium Phosphate Cement Accelerates Bridging of Critical-Sized Defects in Rabbit Radii
J. Bone Joint Surg. Am., July 1, 2006; 88(7): 1553 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
A. H. R. W. Simpson, L. Mills, and B. Noble
The role of growth factors and related agents in accelerating fracture healing
J Bone Joint Surg Br, June 1, 2006; 88-B(6): 701 - 705.
[Full Text] [PDF]


Home page
JBJSHome page
H. Seeherman, R. Li, M. Bouxsein, H. Kim, X. J. Li, E. A. Smith-Adaline, M. Aiolova, and J. M. Wozney
rhBMP-2/Calcium Phosphate Matrix Accelerates Osteotomy-Site Healing in a Nonhuman Primate Model at Multiple Treatment Times and Concentrations
J. Bone Joint Surg. Am., January 1, 2006; 88(1): 144 - 160.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
H. Eckardt, M. Ding, M. Lind, E. S. Hansen, K. S. Christensen, and I. Hvid
Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model
J Bone Joint Surg Br, October 1, 2005; 87-B(10): 1434 - 1438.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. M. Langenfeld, J. Bojnowski, J. Perone, and J. Langenfeld
Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas
Ann. Thorac. Surg., September 1, 2005; 80(3): 1028 - 1032.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Jadlowiec, D. Dongell, J. Smith, C. Conover, and P. Campbell
Pregnancy-Associated Plasma Protein-A Is Involved in Matrix Mineralization of Human Adult Mesenchymal Stem Cells and Angiogenesis in the Chick Chorioallontoic Membrane
Endocrinology, September 1, 2005; 146(9): 3765 - 3772.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. M. Rajamannan, T. B. Nealis, M. Subramaniam, S. Pandya, S. R. Stock, C. I. Ignatiev, T. J. Sebo, T. K. Rosengart, W. D. Edwards, P. M. McCarthy, et al.
Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation
Circulation, June 21, 2005; 111(24): 3296 - 3301.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Ferrari, U. Pfeffer, R. Dell'Eva, C. Ambrosini, D. M. Noonan, and A. Albini
The Transforming Growth Factor-{beta} Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide
Clin. Cancer Res., June 15, 2005; 11(12): 4610 - 4619.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Panopoulou, C. Murphy, H. Rasmussen, E. Bagli, E. K. Rofstad, and T. Fotsis
Activin A Suppresses Neuroblastoma Xenograft Tumor Growth via Antimitotic and Antiangiogenic Mechanisms
Cancer Res., March 1, 2005; 65(5): 1877 - 1886.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. S. Bonnet and D. A. Walsh
Osteoarthritis, angiogenesis and inflammation
Rheumatology, January 1, 2005; 44(1): 7 - 16.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Bostrom, A. F. Zebboudj, Y. Yao, T. S. Lin, and A. Torres
Matrix GLA Protein Stimulates VEGF Expression through Increased Transforming Growth Factor-{beta}1 Activity in Endothelial Cells
J. Biol. Chem., December 17, 2004; 279(51): 52904 - 52913.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Ferrara
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Endocr. Rev., August 1, 2004; 25(4): 581 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F.-S. Wang, C.-J. Wang, Y.-J. Chen, P.-R. Chang, Y.-T. Huang, Y.-C. Sun, H.-C. Huang, Y.-J. Yang, and K. D. Yang
Ras Induction of Superoxide Activates ERK-dependent Angiogenic Transcription Factor HIF-1{alpha} and VEGF-A Expression in Shock Wave-stimulated Osteoblasts
J. Biol. Chem., March 12, 2004; 279(11): 10331 - 10337.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
W.L. Murphy, C.A. Simmons, D. Kaigler, and D.J. Mooney
Bone Regeneration via a Mineral Substrate and Induced Angiogenesis
J. Dent. Res., March 1, 2004; 83(3): 204 - 210.
[Abstract] [Full Text] [PDF]


Home page
FAKE JDRHome page
W.L. Murphy, C.A. Simmons, D. Kaigler, and D.J. Mooney
Bone Regeneration via a Mineral Substrate and Induced Angiogenesis
Journal of Dental Research, March 1, 2004; 83(3): 204 - 210.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
E. M. Langenfeld and J. Langenfeld
Bone Morphogenetic Protein-2 Stimulates Angiogenesis in Developing Tumors
Mol. Cancer Res., March 1, 2004; 2(3): 141 - 149.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Dai, Y. Kitagawa, J. Zhang, Z. Yao, A. Mizokami, S. Cheng, J. Nor, L. K. McCauley, R. S. Taichman, and E. T. Keller
Vascular Endothelial Growth Factor Contributes to the Prostate Cancer-Induced Osteoblast Differentiation Mediated by Bone Morphogenetic Protein
Cancer Res., February 1, 2004; 64(3): 994 - 999.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. Noel, D. Gazit, C. Bouquet, F. Apparailly, C. Bony, P. Plence, V. Millet, G. Turgeman, M. Perricaudet, J. Sany, et al.
Short-Term BMP-2 Expression Is Sufficient for In Vivo Osteochondral Differentiation of Mesenchymal Stem Cells
Stem Cells, January 1, 2004; 22(1): 74 - 85.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. M. Langenfeld, S. E. Calvano, F. Abou-Nukta, S. F. Lowry, P. Amenta, and J. Langenfeld
The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells
Carcinogenesis, September 1, 2003; 24(9): 1445 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Moser, O. Binder, Y. Wu, J. Aitsebaomo, R. Ren, C. Bode, V. L. Bautch, F. L. Conlon, and C. Patterson
BMPER, a Novel Endothelial Cell Precursor-Derived Protein, Antagonizes Bone Morphogenetic Protein Signaling and Endothelial Cell Differentiation
Mol. Cell. Biol., August 15, 2003; 23(16): 5664 - 5679.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Furumatsu, Z. N. Shen, A. Kawai, K. Nishida, H. Manabe, T. Oohashi, H. Inoue, and Y. Ninomiya
Vascular Endothelial Growth Factor Principally Acts as the Main Angiogenic Factor in the Early Stage of Human Osteoblastogenesis
J. Biochem., May 1, 2003; 133(5): 633 - 639.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Maeda, T. Kawane, and N. Horiuchi
Statins Augment Vascular Endothelial Growth Factor Expression in Osteoblastic Cells via Inhibition of Protein Prenylation
Endocrinology, February 1, 2003; 144(2): 681 - 692.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Valdimarsdottir, M.-J. Goumans, A. Rosendahl, M. Brugman, S. Itoh, F. Lebrin, P. Sideras, and P. ten Dijke
Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein-Induced Activation of Endothelial Cells
Circulation, October 22, 2002; 106(17): 2263 - 2270.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Street, M. Bao, L. deGuzman, S. Bunting, F. V. Peale Jr., N. Ferrara, H. Steinmetz, J. Hoeffel, J. L. Cleland, A. Daugherty, et al.
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover
PNAS, July 23, 2002; 99(15): 9656 - 9661.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society